UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis

Taylor, AE; Martin, RM; Geybels, MS; Stanford, JL; Shui, I; Eeles, R; Easton, D; ... Munafò, MR; + view all (2017) Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis. International Journal of Cancer , 140 (2) pp. 322-328. 10.1002/ijc.30462. Green open access

[thumbnail of Taylor_et_al-2017-Coffee consumption and Pca -Mendelian Randomisation- IJC.pdf]
Preview
Text
Taylor_et_al-2017-Coffee consumption and Pca -Mendelian Randomisation- IJC.pdf - Published Version

Download (276kB) | Preview

Abstract

Coffee consumption has been shown in some studies to be associated with lower risk of prostate cancer. However, it is unclear if this association is causal or due to confounding or reverse causality. We conducted a Mendelian randomisation analysis to investigate the causal effects of coffee consumption on prostate cancer risk and progression. We used two genetic variants robustly associated with caffeine intake (rs4410790 and rs2472297) as proxies for coffee consumption in a sample of 46,687 men of European ancestry from 25 studies in the PRACTICAL consortium. Associations between genetic variants and prostate cancer case status, stage and grade were assessed by logistic regression and with all-cause and prostate cancer-specific mortality using Cox proportional hazards regression. There was no clear evidence that a genetic risk score combining rs4410790 and rs2472297 was associated with prostate cancer risk (OR per additional coffee increasing allele: 1.01, 95% CI: 0.98,1.03) or having high-grade compared to low-grade disease (OR: 1.01, 95% CI: 0.97,1.04). There was some evidence that the genetic risk score was associated with higher odds of having nonlocalised compared to localised stage disease (OR: 1.03, 95% CI: 1.01, 1.06). Amongst men with prostate cancer, there was no clear association between the genetic risk score and all-cause mortality (HR: 1.00, 95% CI: 0.97,1.04) or prostate cancer-specific mortality (HR: 1.03, 95% CI: 0.98,1.08). These results, which should have less bias from confounding than observational estimates, are not consistent with a substantial effect of coffee consumption on reducing prostate cancer incidence or progression.

Type: Article
Title: Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/ijc.30462
Publisher version: http://dx.doi.org/10.1002/ijc.30462
Language: English
Additional information: Copyright © 2016 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: Mendelian randomization, coffee, prostate cancer
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Applied Health Research
URI: https://discovery.ucl.ac.uk/id/eprint/1529341
Downloads since deposit
111Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item